CClinicalTrials.gg
CompletedNCT04202926Updated Nov 22, 2023

Repetitive dTMS Intervention for Methamphetamine Addiction

An interventional study of real coil and sham coil in Methamphetamine-dependence, sponsored by Shanghai Mental Health Center. Completed at 1 site in China. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-11-22.

Sponsored by Shanghai Mental Health Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

A growing body of evidence suggests a wide range of brain areas including medial prefrontal cortex (mPFC), dorsolateral prefrontal cortex (DLPFC) and other subcortical regions, such as anterior cingulate cortex (ACC) are critical for regulating cognitive control over decisions and involving in drug related cue processing. Previous studies have demonstrated that transcranial magnetic stimulation (rTMS) over dorsolateral prefrontal cortex reduces craving for meth dependences. Specifically, the H7 coil induces a magnetic field can target mPFC and ACC. In this study, the investigators investigated whether repeated dTMS intervention of medial prefrontal and cingulate cortices in methamphetamine addiction could reduce the subjective craving and improve the cognitive abilities.

Read the detailed description

The study will be conducted at the drug rehabilitation center in China. The whole procedure includes enrollment, pre-intervention evaluation, intervention (for 3 weeks, 5 times a week, 15 times in total), post-intervention evaluation and one month follow up evaluation.

In enrollment session, participants are recruited according to inclusion criteria.

In the pre-intervention evaluation, firstly, participants need complete a questionnaire to assess their demographic information, drug addiction history and drug abstinence. And then are assigned to either 10Hz group or sham group according to the counterbalance of their basic demographic and drug use information. Then, participants need complete craving, cognitive ability and electroencephalogram (EEG) assessment. For craving assessing, participants are shown a video of methamphetamine usage for 5 minutes, and then rated on the visual analogue scale (0 means completely undesired and 100 means extremely wanting) to report their craving for methamphetamine. For cognitive ability and EEG signal assessing, the whole process is conducted on the computer according to instructions.

In the intervention session, dTMS was administered using a TMS stimulator (Magstim, U.K.) equipped with a unique H-shaped coil design. The H-coil version used in this study was the H7 (Brainsway, Jerusalem, Israel). When placed 4-5 cm anterior to the foot motor cortex and used at 100% of the leg resting motor threshold (RMT), the H7 coil stimulates the dorsal mPFC and ACC bilaterally. A participant's RMT was determined before the first treatment and at the beginning of each week by ascertaining the coil position that elicited the minimal involuntary contractions of the feet (three of six attempts). The 10Hz group received 10 Hz dTMS at 100% of RMT, with 3-second pulse and 17-second intervals, for a total of 50 trains and 1500 pulses per session. The sham group received treatment with identical technical parameters, which induced scalp sensations but without penetration of the electric field into the brain.

Post-intervention evaluation and one month follow up evaluation are the same as in pre-intervention evaluation.

To ensure study quality, some measures are taken as bellow:

Researchers and drug rehabilitation staff will work together in whole process and the data will be converted into electronic versions once finishing each evaluation.

In the intervention, patients, operators, and raters were blind to treatment condition. Each patient is assigned a magnetic card that determined the coil (real or sham) in the helmet and raters are not present while treatments are administered.

After each treatment times, any side effect from participant's report are recorded to assure the safety and feasibility.

Statistical analyses are performed using SPSS 21.0. The principal statistical analysis is performed using repeated-measures analysis of variance and regression analysis. All missing data will be recorded and marked.

02

Conditions studied

  • Methamphetamine-dependence

Browse trials for

Keywords

  • deep transcranial magnetic stimulation
  • methamphetamine addiction
03

In context

Behavior, Addictive

540 studies on the registry are indexed under Behavior, Addictive; 134 are open to participants now.

This study's enrollment of 23 is below the median of 72 across 391 interventional studies indexed under Behavior, Addictive.

Browse Behavior, Addictive studies →

Lead sponsor

Shanghai Mental Health Center is the lead sponsor of 267 studies on the registry; 93 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Methamphetamine dependents
  • middle school degree or above

Exclusion criteria

Exclusion Criteria:

  • Have contraindications to rTMS (head trauma, epilepsy or history of epilepsy, metal implant etc.)
  • psychiatric illnesses
  • intellectual impairment (IQ\<90)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    10hz group

    a high frequency stimulation

    Device: real coil

  • Sham comparator
    sham group

    a sham coil which frequency is 10hz but do not induce stimulation

    Device: sham coil

Interventions

  • Devicereal coil

    active 10Hz with a train of 3s on / 17s off, 50 trains, a total of 1500 pulses

  • Devicesham coil

    sham 10Hz with a train of 3s on / 17s off, 50 trains, a total of 1500 pulses

06

What researchers measure

Primary outcomes

  1. Changes of Cue-induced craving and ERP

    Subjective craving (cue induced, 0-100 based VAS, craving scale) and drug cue-ERP (P300 etc. measured)

    Time frame: the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention

Secondary outcomes

  1. Changes of cognition: behavioral inhibition

    using cognitive tasks: stop-signal task

    Time frame: the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention

  2. Changes of cognition: working memory

    using cognitive tasks: n-back task

    Time frame: the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention

  3. Changes of depression status

    depression (Beck Depression inventory scale), high score means worse depression

    Time frame: the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention

  4. Changes of anxiety status

    Anxiety (Beck anxiety inventory scale), higher score means worse anxiety

    Time frame: the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention

  5. Changes of sleep status

    sleep status measurements (Pittsburgh Sleep Quality Index scale), higher score means worse sleep

    Time frame: the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention

  6. Changes of impulsivity

    Impulsivity scale (The Barratt Impulsiveness Scale), higher score means higher impulsivity

    Time frame: the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention

  7. Changes of resting EEG network

    resting EEG signal (Alpha, Beta, Theta, etc) measurement with 128 Channel EGI system

    Time frame: the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention

Other outcomes

  1. side effect measurements

    Side effect scale, including headache, pricking, sleeplessness etc.

    Time frame: every day after each intervention time for the 3 weeks intervention time period

07

Study locations

1 site
  • Nanjing Dalianshan Addiction Rehab Center
    Nanjing, 210090, China
08

References and documents

Publications

  • Shen Y, Cao X, Tan T, Shan C, Wang Y, Pan J, He H, Yuan TF. 10-Hz Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex Reduces Heroin Cue Craving in Long-Term Addicts. Biol Psychiatry. 2016 Aug 1;80(3):e13-4. doi: 10.1016/j.biopsych.2016.02.006. Epub 2016 Feb 12. No abstract available. PubMed 26995024 ↗
  • Dunlop K, Hanlon CA, Downar J. Noninvasive brain stimulation treatments for addiction and major depression. Ann N Y Acad Sci. 2017 Apr;1394(1):31-54. doi: 10.1111/nyas.12985. Epub 2016 Feb 5. PubMed 26849183 ↗
  • Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger DM, Daskalakis J, Ward H, Lapidus K, Goodman W, Casuto L, Feifel D, Barnea-Ygael N, Roth Y, Zangen A, Zohar J. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry. 2019 Nov 1;176(11):931-938. doi: 10.1176/appi.ajp.2019.18101180. Epub 2019 May 21. PubMed 31109199 ↗
  • Liu T, Li Y, Shen Y, Liu X, Yuan TF. Gender does not matter: Add-on repetitive transcranial magnetic stimulation treatment for female methamphetamine dependents. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:70-75. doi: 10.1016/j.pnpbp.2018.12.018. Epub 2018 Dec 31. PubMed 30605708 ↗
  • Su H, Zhong N, Gan H, Wang J, Han H, Chen T, Li X, Ruan X, Zhu Y, Jiang H, Zhao M. High frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex for methamphetamine use disorders: A randomised clinical trial. Drug Alcohol Depend. 2017 Jun 1;175:84-91. doi: 10.1016/j.drugalcdep.2017.01.037. Epub 2017 Mar 29. PubMed 28410525 ↗
  • Liu Q, Shen Y, Cao X, Li Y, Chen Y, Yang W, Yuan TF. Either at left or right, both high and low frequency rTMS of dorsolateral prefrontal cortex decreases cue induced craving for methamphetamine. Am J Addict. 2017 Dec;26(8):776-779. doi: 10.1111/ajad.12638. Epub 2017 Nov 14. PubMed 29134789 ↗

Individual participant data

Plan to share: Yes — share all IPD that underlie results in a publication

Supporting information: Study protocol, Sap, Icf, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04202926
Lead sponsor
Shanghai Mental Health Center
Responsible party
Sponsor
First posted
Dec 18, 2019
Start date
Dec 30, 2019
Primary completion
May 30, 2023
Completion
Oct 30, 2023
Last update
Nov 22, 2023

Study contacts

Tifei Yuan, PhD
principal investigator · Shanghai Mental Health Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion